Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Nutex Health (NUTX) Change in Acquisitions & Divestments (2025)

Nutex Health (NUTX) has disclosed Change in Acquisitions & Divestments for 2 consecutive years, with -$1.3 million as the latest value for Q4 2025.

For Q4 2025, Change in Acquisitions & Divestments changed N/A year-over-year to -$1.3 million; the TTM value through Dec 2025 reached -$1.3 million, down 53900.0%, while the annual FY2025 figure was $1.6 million, N/A changed from the prior year.
Change in Acquisitions & Divestments hit -$1.3 million in Q4 2025 for Nutex Health, down from $2500.0 in the prior quarter.
Across five years, Change in Acquisitions & Divestments topped out at -$1.3 million in Q4 2025 and bottomed at -$1.3 million in Q4 2025.